{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:35:13Z","timestamp":1792899313161,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI063382"],"award-info":[{"award-number":["R01 AI063382"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI063382"],"award-info":[{"award-number":["R01 AI063382"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>NDV-3A, a novel fungal vaccine undergoing clinical trials, contains a recombinant version of the <jats:italic>Candida albicans<\/jats:italic> rAls3 N-terminus protein (rAls3p-N) in aluminum hydroxide. In a Phase 1b\/2a clinical trial, NDV-3A protected women from recurrent vulvovaginal candidiasis. Here, we reveal that active immunization in mice with NDV-3A induces high titers of anti-rAls3p-N antibodies that interfere with <jats:italic>C. albicans<\/jats:italic> ability to adhere to and invade endothelial cells, and form biofilm <jats:italic>in vitro<\/jats:italic>. Anti-rAls3p-N antibodies also significantly inhibit yeast dispersal from the hyphal layers of biofilms. Compared to placebo, NDV-3A vaccination inhibited <jats:italic>C. albicans<\/jats:italic> dissemination to kidneys and prevented colonization of central venous catheters in mice. Overall, these preclinical studies suggest that NDV-3A may serve as an immunotherapeutic strategy for prevention of infections on indwelling medical devices.<\/jats:p>","DOI":"10.1038\/s41598-019-42517-y","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T10:14:19Z","timestamp":1555496059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice"],"prefix":"10.1038","volume":"9","author":[{"given":"Abdullah","family":"Alqarihi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6521-0998","authenticated-orcid":false,"given":"Shakti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John E.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Uppuluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"42517_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/1040841X.2011.576332","volume":"37","author":"M Ilkit","year":"2011","unstructured":"Ilkit, M. & Guzel, A. B. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Crit Rev Microbiol 37, 250\u2013261, https:\/\/doi.org\/10.3109\/1040841X.2011.576332 (2011).","journal-title":"Crit Rev Microbiol"},{"issue":"4","key":"42517_CR2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","volume":"42","author":"R. A. Hajjeh","year":"2004","unstructured":"Hajjeh, R. A. et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42, 1519-1527 (2004).","journal-title":"Journal of Clinical Microbiology"},{"key":"42517_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson, O. et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37, 1172\u20131177, https:\/\/doi.org\/10.1086\/378745 (2003).","journal-title":"Clin Infect Dis"},{"key":"42517_CR4","doi-asserted-by":"publisher","first-page":"ftw018","DOI":"10.1093\/femspd\/ftw018","volume":"74","author":"C Tsui","year":"2016","unstructured":"Tsui, C., Kong, E. F. & Jabra-Rizk, M. A. Pathogenesis of Candida albicans biofilm. Pathog Dis 74, ftw018, https:\/\/doi.org\/10.1093\/femspd\/ftw018 (2016).","journal-title":"Pathog Dis"},{"issue":"1","key":"42517_CR5","doi-asserted-by":"publisher","first-page":"22434","DOI":"10.3402\/jom.v5i0.22434","volume":"5","author":"David W. Williams","year":"2013","unstructured":"Williams, D. W. et al. Interactions of Candida albicans with host epithelial surfaces. J Oral Microbiol 5, https:\/\/doi.org\/10.3402\/jom.v5i0.22434 (2013).","journal-title":"Journal of Oral Microbiology"},{"key":"42517_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","volume":"69","author":"CJ Nobile","year":"2015","unstructured":"Nobile, C. J. & Johnson, A. D. Candida albicans Biofilms and Human Disease. Annu Rev Microbiol 69, 71\u201392, https:\/\/doi.org\/10.1146\/annurev-micro-091014-104330 (2015).","journal-title":"Annu Rev Microbiol"},{"key":"42517_CR7","doi-asserted-by":"publisher","unstructured":"Pierce, C. G. et al. A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance. NPJ Biofilms Microbiomes 1, https:\/\/doi.org\/10.1038\/npjbiofilms.2015.12 (2015).","DOI":"10.1038\/npjbiofilms.2015.12"},{"key":"42517_CR8","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1371\/journal.pbio.0050064","volume":"5","author":"QT Phan","year":"2007","unstructured":"Phan, Q. T. et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5, e64, https:\/\/doi.org\/10.1371\/journal.pbio.0050064 (2007).","journal-title":"PLoS Biol"},{"key":"42517_CR9","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1099\/mic.0.28959-0","volume":"152","author":"X Zhao","year":"2006","unstructured":"Zhao, X. et al. Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology 152, 2287\u20132299, https:\/\/doi.org\/10.1099\/mic.0.28959-0 (2006).","journal-title":"Microbiology"},{"key":"42517_CR10","doi-asserted-by":"publisher","first-page":"e1000217","DOI":"10.1371\/journal.ppat.1000217","volume":"4","author":"RS Almeida","year":"2008","unstructured":"Almeida, R. S. et al. the hyphal-associated adhesin and invasin Als3 of Candida albicans mediates iron acquisition from host ferritin. PLoS Pathog 4, e1000217, https:\/\/doi.org\/10.1371\/journal.ppat.1000217 (2008).","journal-title":"PLoS Pathog"},{"key":"42517_CR11","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cid\/ciy185","volume":"66","author":"JE Edwards Jr.","year":"2018","unstructured":"Edwards, J. E. Jr. et al. A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis 66, 1928\u20131936, https:\/\/doi.org\/10.1093\/cid\/ciy185 (2018).","journal-title":"Clin Infect Dis"},{"key":"42517_CR12","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1016\/j.vaccine.2013.09.016","volume":"31","author":"AS Ibrahim","year":"2013","unstructured":"Ibrahim, A. S. et al. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine 31, 5549\u20135556, https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.016 (2013).","journal-title":"Vaccine"},{"key":"42517_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CVI.00427-07","volume":"15","author":"L Lin","year":"2008","unstructured":"Lin, L. et al. Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant. Clin Vaccine Immunol 15, 582\u2013584, https:\/\/doi.org\/10.1128\/CVI.00427-07 (2008).","journal-title":"Clin Vaccine Immunol"},{"key":"42517_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1086\/529204","volume":"197","author":"B Spellberg","year":"2008","unstructured":"Spellberg, B. et al. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J Infect Dis 197, 967\u2013971, https:\/\/doi.org\/10.1086\/529204 (2008).","journal-title":"J Infect Dis"},{"key":"42517_CR15","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","volume":"30","author":"CS Schmidt","year":"2012","unstructured":"Schmidt, C. S. et al. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30, 7594\u20137600, https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.038 (2012).","journal-title":"Vaccine"},{"key":"42517_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3389\/fimmu.2018.01349","volume":"9","author":"P Uppuluri","year":"2018","unstructured":"Uppuluri, P. et al. Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis. Front Immunol 9, 1349, https:\/\/doi.org\/10.3389\/fimmu.2018.01349 (2018).","journal-title":"Front Immunol"},{"key":"42517_CR17","doi-asserted-by":"publisher","first-page":"e25909","DOI":"10.1371\/journal.pone.0025909","volume":"6","author":"G Luo","year":"2011","unstructured":"Luo, G., Ibrahim, A. S., French, S. W., Edwards, J. E. Jr. & Fu, Y. Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis. PLoS One 6, e25909, https:\/\/doi.org\/10.1371\/journal.pone.0025909 (2011).","journal-title":"PLoS One"},{"key":"42517_CR18","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1086\/652407","volume":"201","author":"G Luo","year":"2010","unstructured":"Luo, G. et al. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis 201, 1718\u20131728, https:\/\/doi.org\/10.1086\/652407 (2010).","journal-title":"J Infect Dis"},{"key":"42517_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2567.2004.01819.x","volume":"111","author":"M Vilanova","year":"2004","unstructured":"Vilanova, M. et al. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology 111, 334\u2013342 (2004).","journal-title":"Immunology"},{"key":"42517_CR20","doi-asserted-by":"publisher","first-page":"e35106","DOI":"10.1371\/journal.pone.0035106","volume":"7","author":"H Xin","year":"2012","unstructured":"Xin, H. et al. Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis. PLoS One 7, e35106, https:\/\/doi.org\/10.1371\/journal.pone.0035106 (2012).","journal-title":"PLoS One"},{"key":"42517_CR21","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1128\/CVI.05215-11","volume":"18","author":"H Xin","year":"2011","unstructured":"Xin, H. & Cutler, J. E. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis. Clin Vaccine Immunol 18, 1656\u20131667, https:\/\/doi.org\/10.1128\/CVI.05215-11 (2011).","journal-title":"Clin Vaccine Immunol"},{"key":"42517_CR22","doi-asserted-by":"publisher","first-page":"e1000828","DOI":"10.1371\/journal.ppat.1000828","volume":"6","author":"P Uppuluri","year":"2010","unstructured":"Uppuluri, P. et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog 6, e1000828, https:\/\/doi.org\/10.1371\/journal.ppat.1000828 (2010).","journal-title":"PLoS Pathog"},{"key":"42517_CR23","doi-asserted-by":"publisher","first-page":"e1005397","DOI":"10.1371\/journal.ppat.1005397","volume":"12","author":"P Uppuluri","year":"2016","unstructured":"Uppuluri, P. & Lopez-Ribot, J. L. G. Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms. PLoS Pathog 12, e1005397, https:\/\/doi.org\/10.1371\/journal.ppat.1005397 (2016).","journal-title":"PLoS Pathog"},{"key":"42517_CR24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CDLI.6.6.924-929.1999","volume":"6","author":"BK Na","year":"1999","unstructured":"Na, B. K. & Song, C. Y. Use of monoclonal antibody in diagnosis of candidiasis caused by Candida albicans: detection of circulating aspartyl proteinase antigen. Clin Diagn Lab Immunol 6, 924\u2013929 (1999).","journal-title":"Clin Diagn Lab Immunol"},{"key":"42517_CR25","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52, 2745\u20132756, https:\/\/doi.org\/10.1172\/JCI107470 (1973).","journal-title":"Identification by morphologic and immunologic criteria. J Clin Invest"},{"key":"42517_CR26","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nport.2008.141","volume":"3","author":"CG Pierce","year":"2008","unstructured":"Pierce, C. G. et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 3, 1494\u20131500, https:\/\/doi.org\/10.1038\/nport.2008.141 (2008).","journal-title":"Nat Protoc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42517-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:50:19Z","timestamp":1671267019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42517-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42517"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42517-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.E.E. and A.S.I. are founders and shareholders of NovaDigm Therapeutics Inc. a company that is developing the NDV-3A as a fungal vaccine. All other co-authors have no formal association with NovaDigm.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6194"}}